Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity
Joel Castro, Andrea M. Harrington, TinaMarie Lieu, Sonia Garcia-Caraballo, Jessica Maddern, Gudrun Schober, Tracey O’Donnell, Luke Grundy, Amanda L. Lumsden, Paul Miller, Andre Ghetti, Martin S. Steinhoff, Daniel P. Poole, Xinzhong Dong, Lin Chang, Nigel W. Bunnett, Stuart M. Brierley
Joel Castro, Andrea M. Harrington, TinaMarie Lieu, Sonia Garcia-Caraballo, Jessica Maddern, Gudrun Schober, Tracey O’Donnell, Luke Grundy, Amanda L. Lumsden, Paul Miller, Andre Ghetti, Martin S. Steinhoff, Daniel P. Poole, Xinzhong Dong, Lin Chang, Nigel W. Bunnett, Stuart M. Brierley
View: Text | PDF
Research Article Gastroenterology Neuroscience

Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity

  • Text
  • PDF
Abstract

Itch induces scratching that removes irritants from the skin, whereas pain initiates withdrawal or avoidance of tissue damage. While pain arises from both the skin and viscera, we investigated whether pruritogenic irritant mechanisms also function within visceral pathways. We show that subsets of colon-innervating sensory neurons in mice express, either individually or in combination, the pruritogenic receptors Tgr5 and the Mas-gene–related GPCRs Mrgpra3 and Mrgprc11. Agonists of these receptors activated subsets of colonic sensory neurons and evoked colonic afferent mechanical hypersensitivity via a TRPA1-dependent mechanism. In vivo intracolonic administration of individual TGR5, MrgprA3, or MrgprC11 agonists induced pronounced visceral hypersensitivity to colorectal distension. Coadministration of these agonists as an “itch cocktail” augmented hypersensitivity to colorectal distension and changed mouse behavior. These irritant mechanisms were maintained and enhanced in a model of chronic visceral hypersensitivity relevant to irritable bowel syndrome. Neurons from human dorsal root ganglia also expressed TGR5, as well as the human ortholog MrgprX1, and showed increased responsiveness to pruritogenic agonists in pathological states. These data support the existence of an irritant-sensing system in the colon that is a visceral representation of the itch pathways found in skin, thereby contributing to sensory disturbances accompanying common intestinal disorders.

Authors

Joel Castro, Andrea M. Harrington, TinaMarie Lieu, Sonia Garcia-Caraballo, Jessica Maddern, Gudrun Schober, Tracey O’Donnell, Luke Grundy, Amanda L. Lumsden, Paul Miller, Andre Ghetti, Martin S. Steinhoff, Daniel P. Poole, Xinzhong Dong, Lin Chang, Nigel W. Bunnett, Stuart M. Brierley

×

Figure 6

In vivo intracolonic administration of TGR5, MrgprA3, and MrgprC11 agonists, alone or in combination, induces visceral hypersensitivity to colorectal distension.

Options: View larger image (or click on image) Download as PowerPoint
In vivo intracolonic administration of TGR5, MrgprA3, and MrgprC11 agoni...
(A) Intracolonic administration of CCDC (100μM) resulted in significantly enhanced visceromotor responses (VMRs) to colorectal distension (CRD) in healthy mice, with significant increases observed across all distension pressures. (B) Group data expressed as the total AUC of the VMR to CRD shows significantly elevated responses following intracolonic CCDC. Each dot represents the total AUC from an individual animal. (C) Tgr5–/– mice administered intracolonic CCDC (100 μM) showed significantly reduced VMRs compared with Tgr5+/+ littermates administered intracolonic CCDC. (D) Significantly reduced total VMRs in Tgr5–/– mice administered CCDC compared with Tgr5+/+. (E) Healthy mice administered intracolonic chloroquine (CQ; 10 μM) have significantly elevated VMRs, particularly at 40–80 mmHg distension. (F) Intracolonic CQ significantly enhanced total VMRs compared with vehicle. (G) Mrgpr-cluster–/– mice intracolonically administered 10 μM CQ did not show altered VMRs nor altered (H) total VMR relative to Mrgpr-cluster–/– mice administered vehicle (P > 0.05). (I) Mice administered intracolonic BAM8-22 (20 μM) have significantly elevated VMRs, particularly at noxious distension pressures of 70–80 mmHg. (J) Intracolonic BAM8-22 significantly enhanced total VMRs compared with vehicle. (K) Mrgpr-cluster–/– mice intracolonically administered 20 μM BAM8-22 had unaltered VMRs and unaltered (L) total VMRs to CRD relative to Mrgpr-cluster–/– mice administered vehicle (P > 0.05). (M) An intracolonic itch cocktail consisting of a combination of CCDC (100 μM), BAM8-22 (20 μM), and CQ (10 μM) significantly enhanced VMRs in healthy mice. This hypersensitivity was evident at 40–50 mmHg, 60–70 mmHg, and 80 mmHg. (N) The itch cocktail also significantly enhanced the total VMR compared with vehicle. (O) Trpa1–/– mice intracolonically administered the itch cocktail did not show altered VMRs relative to vehicle-administered Trpa1–/– mice (P > 0.05). (P) Total VMR was unchanged in Trpa1–/– mice administered the itch cocktail compared with vehicle (P > 0.05). Data represent mean ± SEM. P values determined by generalized estimating equations, followed by least significant difference post hoc tests (A, C, E, G, I, K, M, O) or by unpaired t tests (B, D, F, H, J, L, N, P). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts